Tesamorelin + Ipamorelin vs MK-677

Tesamorelin + Ipamorelin wins for:

• Targeted visceral fat loss (VAT) with sparing of subcutaneous fat
• Pulsatile, physiologic GH/IGF-1 patterns (closer mimicry of natural secretion)
• Cleaner side-effect profile (less fluid retention, minimal appetite surge, lower glucose impact)
• Customizable protocol (timing, dosing, synergy with other injectables)

MK-677 wins for:

• Convenience and compliance (oral dosing, no injections or mixing lyophilized powder)
• Large, sustained (24-hour) elevations in GH and IGF-1 with a single daily dose
• Easy stacking with virtually any protocol—especially for recovery and sleep enhancement
• Affordable, widely available, and stable for long shelf lives

Pick Tesamorelin + Ipamorelin if:

• The goal is reduction in visceral (abdominal) fat with retention of subq fat for a tighter midsection
• Protocol flexibility and precise dial-in of GH pulse timing is desired (e.g., pre-bed fasted, peri-GLP-1)
• There is sensitivity to MK-677's water retention, appetite stimulation, or insulin resistance
• Research aim is maximizing endogenous GH pulses (physiologic, not 24h flat)
• Supporting joint, tendon, and connective-tissue recovery with a minimal side effect footprint

Pick MK-677 if:

• Oral-only protocols are required (no interest or comfort with reconstitution/injection)
• Convenience, long-term compliance, and minimal logistical overhead are top priorities
• Broad-spectrum IGF-1 elevation and slight recomposition is the goal regardless of bodyfat pattern
• Appetite stimulation is actually helpful (bulking, regaining weight, reversing restriction)
• Budget, sourcing, and stability matter (MK-677 is inexpensive and shelf-stable vs. fragile tesamorelin)